Neonatal handling is an experimental paradigm for early experiences. It affects the programming of hypothalamo-pituitary-adrenal (HPA) axis function, known to be sexually dimorphic. Recently leptin, a hormone related to energy balance and secreted mainly by adipocytes, has been implicated in the stress response. We thus determined the effect of neonatal handling on plasma concentrations of corticosterone and leptin of male and female rats under basal conditions and after two consecutive chronic stressors: chronic forced swimming stress and chronic restraint. Handling resulted in lower basal corticosterone levels in both males and females and in a more efficient HPA response, with a large corticosterone surge following the first chronic stressor and a return to basal levels following the second. Handling also resulted in decreased plasma leptin concentrations in males, thus abolishing the sex difference in leptin levels. Furthermore, handling increased body weight while it decreased food intake under basal conditions. Food intake and body weight gain during chronic forced swimming was lower in handled than in non-handled males, while in females these parameters were not influenced by handling. In both males and females, handling resulted in decreased food intake and increased body weight loss during chronic restraint stress. Body weight loss during chronic restraint stress, which is considered an index of maladaptation and ‘depression’, was particularly pronounced in the handled females. Our results also showed that non-handled females had higher corticosterone and lower leptin levels than males under basal conditions and following each of the two chronic stressors. The present work suggests that early experiences, such as the mother–infant relationship, interact with endogenous factors, such as gonadal hormones, to determine the organism’s response to stressful stimuli during adulthood.

1.
McEwen BS: Allostasis and allostatic load: Implications for neuropsychopharmacology. Neuropsychopharmacology 2000;22:108–124.
2.
Levine S: Infantile experience and resistance to physiological stress. Science 1957;126:405–406.
3.
Levine S: Maternal behavior as a mediator of pup adrenocortical function. Ann NY Acad Sci 1994;746:260–275.
4.
Levine S: Plasma free corticosteroid response to electric shock in rats stimulated in infancy. Science 1962;135:795–796.
5.
Plotsky PM, Meaney MJ: Postnatal handling alters hypothalamic CRF mRNA, synthesis and release. Mol Brain Res 1993;18:195–200.
6.
Viau V, Sharma S, Plotsky PM, Meaney MJ: Increased plasma ACTH response to stress in non-handled compared with handled rats require basal levels of corticosterone and are associated with increased levels of ACTH secretagogues in the median eminence. J Neurosci 1993;13:1097–1105.
7.
Bhatnagar S, Meaney MJ: Hypothalamic-pituitary-adrenal function in chronic intermittently cold stressed neonatally handled and non-handled rats. J Neuroendocrinol 1995;7:97–108.
8.
Hess JL, Dennenberg VH, Zarrow MX, Pfeifer WD: Modification of the corticosterone response curve as a function of handling in infancy. Physiol Behav 1969;4:109–12.
9.
Meaney MJ, Aitken DH, Viau V, Sharma S, Sarrieau A: Neonatal handling alters adrenocortical negative feedback sensitivity and hippocampal glucocorticoid receptor binding in the rat. Neuroendocrinology 1989;50:597–604.
10.
Meaney MJ, Diorio J, Francis D, Widdowson J, La Planta P, Caldji C, Sharma S, Seckl JR, Plotsky PM: Early environmental regulation of forebrain glucorticoid receptor gene expression: Implications for adrenocortical responses to stress. Dev Neurosci 1996;18:49–72.
11.
Meaney MJ, Aitken DH, Bodnoff SR, Iny LJ, Tatarcwicz JE, Sapolsky RM: Early, postnatal handling alters glucocorticoid receptor concentrations in selected brain regions. Behav Neurosci 1985;99:760–765.
12.
O’Donnel D, Larocque S, Seckl, JR, Meaney MJ: Postnatal handling alters glucocorticoid but not mineralocorticoid messenger RNA expression in the hippocampus of adult rats. Mol Brain Res 1994;26:242–248.
13.
Moore CL, Moralli GA: Mother rats interact differently with male and female offspring. J Comp Physiol Psychol 1979;93:677–684.
14.
Critchlow V, Liebelt RA, Bar-Sela, Mountcastle W, Lipscomb HS: Sex difference in resting pituitary-adrenal function in the rat. Am J Physiol 1963;205:807–815.
15.
Kitay JI: Sex differences in adrenal cortical secretion in the rat. Endocrinology 1961;68:818–824.
16.
Gala RR, Westphal U: Corticosteroid-binding globulin in the rat: Studies on the sex difference. Endocrinology 1965;77:841–851.
17.
Hiroshige T, Waka-Okada S: Diurnal changes of hypothalamic content of corticotrophin-releasing activity in female rats at various stages of the estrous cycle. Neuroendocrinology 1973;12:316–319.
18.
Patchev VK, Hayashi S, Orikasa C, Almeida OFX: Implications of estrogen dependent brain organization for gender differences in hypothalamic-pituitary-adrenal regulation. FASEB J 1995;9:419–423.
19.
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425–432.
20.
Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW, Flier JS: Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 1997;138:1358–1363.
21.
Glasow A, Bornstein SR: Leptin and the adrenal gland. Eur J Clin Invest 2000;30:39–45.
22.
Woods SC, Seeley RJ, Porte D, Schwartz MW: Signals that regulate food intake and energy homeostasis. Science 1998;280:1378–1383.
23.
De Vos P, Saladin R, Auwerx J, Staels B: Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 1995;270:15958–15961.
24.
Slieker LJ, Sloop KW, Surface PL, Kriaciunas A, La Quier F, Manetta J, Bue-Valleskey J, Stephens TW: Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem 1996;271:5301–5304.
25.
Chavez M, Seeley RJ, Green PK, Wilkinson CW, Schwartz MW, Woods SC: Adrenalectomy increases sensitivity to central insulin. Physiol Behav 1997;62:631–634.
26.
Zakrzewska KE, Cusin I, Stricker-Krongrad A, Boss O, Ricquier D, Jeanrenaud B, Rohner-Jeanrenaud F: Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat. Diabetes 1999;48:365–370.
27.
Green PK, Wilkinson CW, Woods SC: Intraventricular corticosterone increases the rate of body weight gain in underweight adrenalectomized rats. Endocrinology 1992;130:269–275.
28.
Ponsalle P, Srivastava LX, Uht RM, White JD: Glucocorticoids are required for food deprivation-induced increases in hypothalamic neuropeptide Y expression. J Neuroendocrinol 1992;4:585–591.
29.
Plotsky PM, Thrivikraman KV, Watts AG, Hauger RL: Hypothalamic-pituitary-adrenal axis function in the Zucker obese rat. Endocrinology 1992;130:1931–1941.
30.
Garthwaite TL, Martinson DR, Tseng LF, Hagen TC, Menahan LA: A longitudinal hormonal profile of the genetically obese mouse. Endocrinology 1980;107:671–676.
31.
Jacobson L: Glucocorticoid replacement, but not CRH deficiency, prevents adrenalectomy-induced anorexia in mice. Endocrinology 1999;140:310–317.
32.
Solano JM, Jacobson L: Glucocorticoids reverse leptin effects on food intake and body fat in mice without increasing NPY mRNA. Am J Physiol 1999;277:E708–E716.
33.
Mystkowski P, Schwartz MW: Gonadal steroids and energy homeostasis in the leptin era. Nutrition 2000;16:937–946.
34.
Gentry RT, Wade GN: Androgenic control of food intake and body weight in male rats. J Comp Physiol Psychol 1976;90:747–754.
35.
Blaustein JD, Wade GN: Ovarian influences on the meal patterns of female rats. Physiol Behav 1976;17:201–208.
36.
Wade G: Some effects of ovarian hormones on food intake and body weight in female rats. J Comp Physiol Psychol 1975;88:183–193.
37.
Asarian L, Geary N: Cyclic estradiol treatment normalizes body weight and restores physiological patterns of spontaneous feeding and sexual receptivity in ovariectomized rats. Horm Behav 2002;42:461–471.
38.
Bernstein IL, Courtney L, Braget DJ: Estrogens and the Leydig LTW (m) tumor syndrome: Anorexia and diet aversions attenuated by area postrema lesions. Physiol Behav 1986;38:159–163.
39.
Papaioanou A, Gerozissis K, Prokopiou A, Bolaris S, Stylianopoulou F: Sex differences in the effects of neonatal handling on the animal’s response to stress and the vulnerability for depressive behaviour. Behav Brain Res 2002;129:131–139.
40.
O’ Brien K, Vincent N: Psychiatric comorbidity in anorexia and bulimia nervosa: Nature, prevalence and causal relationships. Clin Psychol Rev 2003;23:57–74.
41.
Earls F: Sex differences in psychiatric disorders: Origins and developmental influences. Psychiatr Dev 1987;5:1–23.
42.
Smythe JW, Mc Cormick CM, Meaney MJ: Median eminence corticotropin-releasing hormone content following prenatal stress and neonatal handling. Brain Res Bull 1996;40:195–199.
43.
Vallee M, Mayo W, Maccari S, Le Moal M, Simon H: Long-term effects of prenatal stress and handling on metabolic parameters: Relationship to corticosterone secretion response. Brain Res 1996;712:287–292.
44.
Kitraki E, Karandrea D, Kittas C: Long lasting effects of stress on glucocorticoid receptor gene expression in the rat brain. Neuroendocrinology 1999;69:331–338.
45.
King JA, Abend S, Edwards E: Genetic predisposition and the development of posttraumatic stress disorder in an animal model. Biol Psychiatry 2001;501:231–237.
46.
Kamphuis PJ, Bakker JM, Broekhoven MH, Kunne C, Croiset G, Lentjes EG, Tilders FJ, van Bel F, Wiegant VM: Enhanced glucocorticoid feedback inhibition of hypothalamo-pituitary-adrenal responses to stress in adult rats neonatally treated with dexamethasone. Neuroendocrinology 2002;76:158–169.
47.
Novak MA: Self-injurious behavior in rhesus monkeys: New insights into its etiology, physiology and treatment. Am J Primatol 2003;59:3–19.
48.
Handa RJ, Burgess LH, Kerr JE, O’Keefe JA: Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Horm Behav 1994;28:464–476.
49.
McCormick CM, Furey BF, Child M, Sawyer MJ, Donohue SM: Neonatal sex hormones have ‘organizational’ effects on the hypothalamic-pituitary-adrenal axis of male rats. Dev Brain Res 1998;105:295–307.
50.
Landt M, Gingerich RL, Havel PJ, Mueller WM, Schoner B, Hale JE, Heiman ML: Radioimmunoassay of rat leptin: Sexual dimorphism reversed from humans. Clin Chem 1998;44:565–570.
51.
Pinilla L, Seoane LM, Gonzalez L, Carro E, Aguilar E, Casanueva FF, Dieguez C: Regulation of serum leptin levels by gonadal function in rats. Eur J Endocrinol 1999;140:468–473.
52.
Bjorntorp P, Rosmond R: Obesity and cortisol. Nutrition 2000;16:924–936.
53.
Bjorntorp P: Do stress reactions cause abdominal obesity and comorbidities? Obes Rev 2001;2:73–86.
54.
Dallman MF, Strack AM, Akana SF, Bradbury MJ, Hanson ES., Scribner KA, Smith M: Feast and famine critical role of glucocorticoids with insulin in daily energy flow; in Martini L, Ganong WF (eds): Frontiers in Neuroendocrinology. New York, Raven Press, 1993, pp 303–347.
55.
Harris R, Mitchell T, Simpson J, Redmann S, Youngblood B, Ryan D: Weight loss in rats exposed to repeated acute restraint stress is independent of energy or leptin status. Am J Physiol Regul Integr Comp Physiol 2002;282:R77–R88.
56.
Curzon G: 5-Hydroxytryptamine and corticosterone in an animal model of depression. Prog Neuropsychopharmacol Biol Psychiatry 1989;13:305–310.
57.
Porsolt RD, LePichon M, Jalfre M: Depression: A new animal model sensitive to antidepressant treatments. Nature 1997;266:730–732.
58.
Gold PW, Wong ML, Chrousos GP, Licinio J: Stress system abnormalities in melancholic and atypical depression: Molecular, pathophysiological, and therapeutic implications. Mol Psychiatry 1996;1:257–264.
59.
Kraus T, Haack M, Schuld A, Hinze-Selch D, Pollmacher T: Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinology 2001;73:243–247.
60.
Hebebrand J, van der Heyden J, Devos R, Kopp W, Herpertz S, Remschmidt H, Herzog W: Plasma concentrations of obese protein in anorexia nervosa. Lancet 1995;346:1624–1625.
61.
Swaab DF, Hofman MA: Sexual differentiation of the human hypothalamus in relation to gender and sexual orientation. Trends Neurosci 1995;18:264–270.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.